MINFIN 10% TOPICAL SOLUTION contains Minoxidil which belongs to the group of medicines called Vasodilators. It is used to manage hereditary hair loss (androgenic alopecia) on the head in men and women. MINFIN 10% TOPICAL SOLUTION is used to manage only mild to moderate hair loss problems, not complete hair loss and helps to stimulate hair growth in such cases.

Uses Of MINFIN 10% TOPICAL SOLUTION

• Management of hair loss (androgenetic alopecia)

How MINFIN 10% TOPICAL SOLUTION Works

MINFIN 10% TOPICAL SOLUTION regrows hair and stabilizes hair loss in men with a receding hairline and head balding by the revitalization of hair follicles. Revitalization of hair follicles is by MINFIN 10% TOPICAL SOLUTION vasodilatory action that helps to increase the blood flow when applied to the scalp. This increased blood flow helps to provide more nutrition and oxygen to the hair follicles thus managing hair cell death and enhancing new hair growth.

How to use MINFIN 10% TOPICAL SOLUTION

Always use MINFIN 10% TOPICAL SOLUTION as directed by your physician. It is for external use only. This medicine is for use on the normal healthy scalp only. Apply MINFIN 10% TOPICAL SOLUTION directly on dry scalp and hair. Do not use it on inflamed, infected, irritated or painful scalp skin. Do not apply to any other parts of the body. Avoid contact with your eyes. Your doctor will decide the required dose and duration of MINFIN 10% TOPICAL SOLUTION for you as per your age and disease condition.

Side Effects Of MINFIN 10% TOPICAL SOLUTION

How To Manage Side Effects

Headache

Drink ample amount of water and avoid skipping meals. Get adequate rest. Try to be relaxed and stress-free. Consult your doctor regarding your symptoms and take medicine accordingly.

Warning & Precautions

Pregnancy

Contraindicated

MINFIN 10% TOPICAL SOLUTION is not recommended for use in pregnant women and in women who are trying to get pregnant. Consult your doctor before using MINFIN 10% TOPICAL SOLUTION.

Breastfeeding

Contraindicated

MINFIN 10% TOPICAL SOLUTION is not recommended for use in breastfeeding women. Consult your doctor for advice.

Driving and Using Machines

Use with Caution

Do not drive or operate any machines if you feel dizzy or experience low blood pressure after using MINFIN 10% TOPICAL SOLUTION.

Allergy

Contraindicated

Do not use MINFIN 10% TOPICAL SOLUTION if you are allergic to minoxidil or any other ingredients of this medicine.

Heart Disease

Consult your doctor

MINFIN 10% TOPICAL SOLUTION is not recommended for use in patients suffering from high blood pressure and must be used with caution in patients suffering from abnormal heart rhythms or rates, chest pains or circulation disorders. Consult your doctor before using MINFIN 10% TOPICAL SOLUTION.

Use In Pediatrics

Contraindicated

MINFIN 10% TOPICAL SOLUTION is not recommended for use in children and adolescents below 18 years of age. Consult your child’s doctor for advice.

Use In Geriatrics

Contraindicated

MINFIN 10% TOPICAL SOLUTION is not recommended for use in elderly patients (aged 65 years and above). Consult your doctor before using MINFIN 10% TOPICAL SOLUTION.

Interactions

A. Drug-Drug interactions:

• medicines that are applied on the scalp
• corticosteroids such as prednisone, hydrocortisone (used to manage inflammatory conditions)
• tretinoin (used to manage acne or other skin diseases)
• petrolatum (uses as a moisturizer to manage dry or itchy skin)
• dithranol (used to manage chronic plaque psoriasis)
• medicines used to manage high blood pressure such as vasodilators (Ex. Hydralazine) or guanethidine

Overdosage:

If you or anyone else accidentally use too much of [GBNKEYWORD on a larger area of skin or on an area other than the scalp or on damaged skin (due to trauma, inflammation or a diseased condition), it may cause a systemic effect then to contact your doctor immediately. Symptoms of MINFIN 10% TOPICAL SOLUTION overdose include cardiovascular reactions such as low blood pressure, rapid heart rate and lethargy.

Synopsis

More Information

FAQs About MINFIN 10% TOPICAL SOLUTION

Q: What is MINFIN 10% TOPICAL SOLUTION used for?

A: MINFIN 10% TOPICAL SOLUTION contains Minoxidil which belongs to the group of medicines called vasodilators. It is used in the management of hair loss (androgenic alopecia) in men and women. MINFIN 10% TOPICAL SOLUTION is used to manage only mild to moderate hair loss problems and not complete hair loss and helps to stimulate hair growth in such cases.

Q: How to use MINFIN 10% TOPICAL SOLUTION?

A: Always use MINFIN 10% TOPICAL SOLUTION as directed by your physician. It is for external use only. This medicine is for use on the normal healthy scalp only. Apply MINFIN 10% TOPICAL SOLUTION directly on dry scalp and hair. Do not use it on inflamed, infected, irritated or painful scalp skin. Do not apply to any other part of the body. Avoid contact with your eyes. Your doctor will decide the required dose and duration of MINFIN 10% TOPICAL SOLUTION for you as per your age and disease condition.

Q: Can MINFIN 10% TOPICAL SOLUTION cause loss of hair after use?

A: In the first couple of months, MINFIN 10% TOPICAL SOLUTION may cause increased hair shedding after use in some individuals. There is a temporary increase in the shedding of hair that generally occurs between 2 and 6 weeks after the start of management and then decreases. If increased shedding continues after 6 weeks of MINFIN 10% TOPICAL SOLUTION use, consult your doctor.

Q: How long should I use MINFIN 10% TOPICAL SOLUTION?

A: Since hair grows slowly, MINFIN 10% TOPICAL SOLUTION takes time to work. Results may be seen in 2-4 months with daily use. If there’s no hair regrowth after 4 months, then consult your doctor. The amount of hair regrowth is different for each person and may not work for all. Continued use of MINFIN 10% TOPICAL SOLUTION is necessary to increase and maintain hair re-growth or hair loss will begin again.

Q: What are the common side effects of using MINFIN 10% TOPICAL SOLUTION?

A: The most common side effects of applying MINFIN 10% TOPICAL SOLUTION are headache, itching of the scalp, rash, burning sensation and excessive hair growth. Consult your doctor in case any of the side effects worsen or persist for long.

Q: When should I avoid using MINFIN 10% TOPICAL SOLUTION?

A: MINFIN 10% TOPICAL SOLUTION is not to be used in cases of the pattern of your hair loss differs from a receding hairline and crown balding, have no family history of hair loss, have total baldness or complete loss of all body hair, have inflamed, infected, irritated or painful scalp, have any condition that affects your scalp such as sunburn and psoriasis and are currently using other medications that are being applied on the scalp. Consult your doctor for a proper physical examination of the scalp before using MINFIN 10% TOPICAL SOLUTION.

Q: What if I accidentally ingest MINFIN 10% TOPICAL SOLUTION?

A: Accidental ingestion of MINFIN 10% TOPICAL SOLUTION may cause serious cardiac adverse events related to low blood pressure such as chest pain, rapid heartbeat, fainting, dizziness, sudden unexplained weight gain or swollen hands and feet. Consult your immediately if any such symptom arises. Keep MINFIN 10% TOPICAL SOLUTION out of the reach of children to avoid such accidents.

Q: What does MINFIN 10% TOPICAL SOLUTION contain?

A: MINFIN 10% TOPICAL SOLUTION contains Minoxidil which belongs to the group of medicines called vasodilators.

References

1. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page-2592-2596.

2. Ghonemy, Soheir, Abeer Alarawi and Hagar Bessar. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation. National Library of Medicine, National center for biotechnology information.Pubmed.gov.2021. [Accessed on 12th July 2024] https://pubmed.ncbi.nlm.nih.gov/31403367/

3. Suchonwanit, Poonkiat, Sasima Thammarucha and Kanchana Leerunyakul. Minoxidil and its use in hair disorders: a review. National Library of Medicine, National center for biotechnology information. Pubmed.gov. 2019. [Accessed on 12th July 2024] https://pubmed.ncbi.nlm.nih.gov/3549810/

4. Janssen-Cilag. Regaine 50 mg/mL skin solution (Minoxidil). [Revised in November 2021] [Accessed on 12th July 2024] https://www.ravimiregister.ee/Data/PIL_ENG/PIL_8824_ENG.pdf

5. Janssen-Cilag. Minoxidil 2% Scalp solution. [Revised in November 2020] [Accessed on 12th July 2024] https://www.regaine.co.uk/sites/regaine_uk/files/pil.102.pdf

6. Rogaine 50 mg/g, cutaneous foam (Minoxidil). Package leaflet. [Revised in July 2018] [Accessed on 12th July 2024] https://docetp.mpa.se/LMF/Rogaine%20cutaneous%20foam%20ENG%20PL_09001bee807a80a1.pdf

7. Wrafton Laboratories Limited. Electronic Medicine Compendium (EMC). [Revised in April 2017] [Accessed on 12th July 2024] https://www.medicines.org.uk/emc/files/pil.8303.pdf

8. Proel Pharmaceutical Industry. Minoxidil/Target 5% w/v cutaneous solution. [Revised in December 2012] [Accessed on 12th July 2024] https://www.targetpharma.gr/wp-content/uploads/2017/10/Minoxidil_Target_EN_PIL_2661901_v4_en.pdf

Author Details

Written By Srilekha. R - B.Pharm

Reviewed By Dr. Sankara Babu Gorle - MBBS, MD(Pharmacology) View profile

Last updated on 10 Sep 2024 | 03:20 PM(IST)